Skip to content

Longitudinal Adverse-Plasticity Registry

Register — instantiates Reopened Malleability Window

Preserves across cases and sites what single sessions drop — delayed harms, null results, subgroup variation, and protocol changes — so the reopening model gets corrected rather than re-sold.

A hazardous reopening method survives on its success stories unless something remembers the rest. Longitudinal Adverse-Plasticity Registry is the durable cross-case memory that keeps the unflattering evidence — the nulls, the delayed harms that surface years later, the subgroups where it failed, the protocol versions that were quietly changed — on equal footing with the wins, and ties each outcome to the exact protocol that produced it. Its distinguishing move is that it exists to enable independent replication and model update: not to measure a single case, but to aggregate across cases and sites over long horizons so the reopening model can be falsified and corrected rather than re-marketed on a handful of good outcomes.

Example

Beyond the usual critical period, several clinics offer experimental treatments that claim to reopen visual-cortex plasticity to recover acuity in an adult's amblyopic eye. Each clinic's own case series looks encouraging. A shared registry collects every case — successes, nulls, and dropouts alike — tagged by induction variant, patient subgroup, and follow-up horizon, and keeps following them for years. Aggregated, a pattern no single clinic could see emerges: one induction variant produced durable gains only in a narrow subgroup, and elsewhere was associated with a delayed adverse effect that never showed up inside the treatment window. That record forces a model update — the trigger's indication is narrowed and a new contraindication is added upstream. Without the registry, those nulls and delayed harms stay in a dozen separate file drawers and the method keeps being offered on its success stories alone.

How it works

The registry is defined by what it refuses to forget and how it attributes it:

  • Symmetric capture — nulls, dropouts, and delayed adverse plasticity are recorded as diligently as successes, so the record does not drift into a gallery of wins.
  • Long-horizon follow-up — cases are tracked over years, because the adverse plasticity that matters most often appears well after the session and the study that ran it has closed.
  • Version-tagged attribution — every outcome is tied to the specific trigger and protocol version and to subgroup, so a change in results can be traced to a change in method and the model updated accordingly.
  • Built for independent re-analysis — structured so parties other than the originators can query, reproduce, and challenge the conclusions.

Tuning parameters

  • Capture completeness — how aggressively nulls, dropouts, and harms are pursued versus left to voluntary reporting. Mandatory capture fights bias but costs infrastructure and cooperation.
  • Follow-up horizon — how long cases are tracked. Longer horizons catch delayed harms but strain funding and retention.
  • Granularity — how finely outcomes are resolved by subgroup and protocol version. Finer resolution enables real model updates but risks small, over-interpreted cells.
  • Access and independence — how open the record is to outside re-analysis. Broader access enables genuine replication; tighter control protects participants but can shield a method from scrutiny.

When it helps, and when it misleads

Its strength is that it is the enterprise's corrective conscience across time — the standing antidote to a risky method being re-sold on cherry-picked cases. By preserving nulls and delayed harms and attributing them to versions, it turns scattered anecdotes into a signal strong enough to narrow an indication, add a contraindication, or retire a trigger.

Its failure modes invert its purpose. A voluntary registry fills with successes and buries the nulls — the file-drawer problem operating at institutional scale,[1] leaving the aggregate as biased as the anecdotes it was meant to correct. Too-short horizons miss exactly the delayed harms it exists to catch, and weak version-tagging makes outcomes unattributable, so nothing can actually be updated. The discipline is mandatory, symmetric capture of nulls and harms, horizons long enough for delayed effects, version-tagged records, and access open enough for independent replication.

How it implements the components

The registry realizes the archetype's institutional-memory component — the record that lets the model be corrected across cases:

  • independent_replication_and_model_update_record — its entire function: the durable, version-tagged, cross-case record that preserves nulls, delayed harms, subgroup variation, and protocol changes, and makes independent replication and model correction possible.

It does NOT measure a single case's delayed outcome (Delayed Retention, Transfer, and Interference Battery), probe protected functions within one session (Non-Target Change Probe Battery), or hold in-session stop authority (Adaptive Stop, Reclosure, and Rescue Protocol) — it consumes their outputs and preserves them.

Notes

A registry is only as honest as its capture rule. Left to voluntary reporting, it becomes a success gallery — the very bias it was built to defeat, now wearing the authority of an aggregate. The load-bearing design choice is mandatory, symmetric capture of nulls, dropouts, and delayed harms; everything else is secondary to that.

References

[1] The file-drawer problem (publication bias) — null and unfavorable results are disproportionately left unpublished, so the visible record overstates an effect. A registry that captures outcomes only when someone volunteers them reproduces this bias at scale, which is why symmetric, mandatory capture is the defining requirement rather than a nicety. ↩